ClinicalTrials.Veeva

Menu

Evaluation of Dry Eye and Meibomian Gland Dysfunction After Cataract Surgery

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Meibomian Gland Dysfunction

Study type

Observational

Funder types

Other

Identifiers

NCT01942642
4-2012-0690

Details and patient eligibility

About

Meibomian gland dysfunction (MGD) is a common and important disease has been investigated the pathophysiology, diagnosis, treatment modalities of MGD, however, the changes of MGD after the cataract surgery, the most popular surgery to ophthalmologist, had not been evaluated. The investigators evaluated parameters related with MGD including lid margin abnormalities, meibomian gland expressibility and meibography before and after surgery.

Enrollment

48 patients

Sex

All

Ages

45 to 88 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients scheduled for cataract surgery

Exclusion criteria

  1. other comorbid ocular diseases such as ocular allergies.
  2. continuous use of topical ocular medications before surgery
  3. histories of ocular surgery, or ocular injury
  4. Already had severe obstructive MGD before surgery, abnormal findings on lid margin (> 3 positive findings), reduced meibum expression (> grade 2), and obstructed gland dropout (meibography score > 3)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems